Natera

194.76
开盘价
190.00
市值
27.57B+
最高价
197.53
最低价
188.50
收盘价
192.54
成交量
2.15K+
市盈率
-126.67
股息率
0.00%

Natera简介

Natera Inc 是一家诊断和研究公司,拥有专有的分子和生物信息学技术。 该公司的主要产品包括:全景无创产前检测 (NIPT),用于筛查胎儿和双胞胎的染色体异常,通常是从母亲那里抽血;Horizon携带者筛查(HCS),用于确定大量可能遗传给携带者子女的严重遗传疾病的携带者状态;Signatera 分子残留病 (MRD) 检测,可检测先前被诊断患有癌症的患者的循环肿瘤 DNA,以评估分子残留病并监测复发情况; 和 Prospera,评估器官移植排斥反应。

如何购买 Natera (NTRA)

登录
1分钟开户

1分钟开户

仅需1分钟即可完成账户申请和验证。整个过程完全自助,支持 RockFlow App 和网页端操作。

充值资金

充值资金

账户验证完成后,您可以使用首选的支付方式向账户充值。

购买 NTRA

购买 NTRA

通过 RockFlow App 或网页端搜索 NTRA,输入您想要投资的金额,然后点击确认即可完成交易。

logo

社交媒体

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.